EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
September 30, 2025 1.414
June 30, 2025 -0.30
March 31, 2025 -0.2435
December 31, 2024 -0.1558
September 30, 2024 1.649
June 30, 2024 -0.3482
March 31, 2024 -0.3414
December 31, 2023 -0.416
September 30, 2023 -0.2365
June 30, 2023 -0.3277
March 31, 2023 -0.2914
December 31, 2022 -0.6737
September 30, 2022 -0.2527
June 30, 2022 -0.3269
March 31, 2022 -0.0905
December 31, 2021 -0.0118
Date Value
September 30, 2021 -0.9076
June 30, 2021 -0.9844
March 31, 2021 -0.744
December 31, 2020 -0.3841
September 30, 2020 -0.2313
June 30, 2020 -0.0606
March 31, 2020 -0.1406
December 31, 2019 0.00
September 30, 2019 0.00
June 30, 2019 0.00
March 31, 2019 -0.1294
December 31, 2018 0.00
September 30, 2018 0.00
June 30, 2018 0.00
March 31, 2018 0.00

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
PAION AG --
Anbio Biotechnology --
Epigenomics AG --
ACADIA Pharmaceuticals, Inc. 0.1822
Alkermes Plc 0.0029

EPS Diluted (Quarterly) Related Metrics